Uncategorized Archives - Page 234 of 248

ThursdayJun 22, 2017 3:41 pm

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Takes Additional Step toward Clinical Trials for INM-750

Moving toward offering the very first therapy for treating epidermolysis bullosa (EB), InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) recently announced it has signed an agreement with Pharmaseed Ltd. (http://nnw.fm/4lZzC) to develop a final formulation for INM-750, InMed’s lead compound, which is being developed as a therapy for EB and for other potential dermatological and wound-healing applications. EB is a group of inherited connective tissue diseases sharing a common manifestation of very fragile skin that is prone to easily blistering or tearing. An orphan disease that currently has no approved treatments and has significant unmet medical need, EB results from…

ThursdayJun 22, 2017 3:24 pm

ChineseInvestors.com, Inc. (CIIX) Raises Profile, Increases Revenues from Investor Relations Activity

ChineseInvestors.com, Inc. (OTCQB: CIIX) has been closely monitored for its upside as it competes in the hemp-derived cannabis market. CIIX has launched a cannabidiol (CBD) online store in the free-trade zone of Shanghai and soon it plans to open a brick-and-mortar store in its home market of San Gabriel, California, to market a line of food and nutrition products. However, the bulk of its existing business remains in investor relations, which is growing as the company invests more in personnel and advertising, successfully raising its profile. CIIX offers a variety of consulting services to Chinese-speaking clients and companies. It offers…

ThursdayJun 22, 2017 9:00 am

Diverse Opportunities Aplenty for Investors Interested in the Marijuana Market

CannabisNewsWire Editorial Coverage: Within the exploding legalized marijuana industry, new innovations and investment opportunities are cropping up all the time; no matter what sector you have interest in, there is likely an investment option to be explored. Among enterprising companies looking for innovative ways to profit within the blossoming marijuana market, SinglePoint, Inc. (SING) (SING Profile), First Bitcoin Capital Corp. (BITCF), Kush Bottles, Inc. (KSHB), Medical Marijuana, Inc. (MJNA) and Solis Tek, Inc. (SLTK) offer diverse opportunities for savvy investors interested in a marijuana-related play. The growth of the legal marijuana market has been bigger and faster than the growth…

WednesdayJun 21, 2017 9:46 am

Algae Dynamics Corp. (ADYNF) is “One to Watch”

Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives…

TuesdayJun 20, 2017 3:53 pm

InMed Pharmaceuticals, Inc. (IMLFF) is a Player in the Billion Dollar Cannabis Biotech Market

Despite the fire-breathing from Attorney-General Jefferson Beauregard Sessions III, there is a distinct feeling that marijuana has entered the mainstream now that Goldman Sachs has initiated coverage on GW Pharma (NASDAQ: GWPH). GW Pharma is the biopharmaceutical that developed the cannabinoid-derived Sativex to treat spasticity due to multiple sclerosis (MS), now approved by regulatory authorities in 29 countries. The success of GW Pharma and other pharmaceutical companies focused on cannabinoid research has produced an exciting new field with a lot of promise, cannabis biotech, and InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is staking a position in that emerging market.…

MondayJun 19, 2017 2:41 pm

InMed Pharmaceuticals, Inc. (IMLFF) Gains Attention for Its Operational Developments and Leadership Team

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team. Insider Financial highlighted InMed Pharmaceuticals as a “Cannabis Runner” in an article back in January, stating that “This is the kind of company that needs to maintain a positive news flow in order to keep investors interested.” More recently, Forbes released an article describing the company as “more than just another cannabis drug…

ThursdayJun 15, 2017 11:23 am

SinglePoint, Inc. (SING) Using Bitcoin to Bypass Banking Roadblocks

A total of 29 states now allow for comprehensive medical marijuana programs, and recreational marijuana is legal in eight. There’s no question that the country’s opinion of marijuana has changed. Public support for making marijuana legal has continued to climb over the years, as 61 percent of Americans now think recreational use of marijuana should be legal and 88 percent favor medical marijuana use. A vast majority of the states and the citizens of this country support legalized marijuana in spite of antiquated federal government strictures. These antiquated federal strictures create conflict. The states where it has been legalized, the…

ThursdayJun 15, 2017 8:00 am

Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments

CannabisNewsWire Editorial Coverage: Alzheimer’s disease is a devastating brain disorder that now affects about 5.3 million Americans, accounting for one in nine people over the age of 65, according to the Alzheimer’s Association. One in three seniors die with the disease or another form of dementia, and, while treatments to slow or stop the disease’s progression have been lacking, several pharmaceutical companies are working to change that. India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), which has products that are backed by data of cannabis-based combination therapies to treat Alzheimer’s, pain, seizures and a host of neurological and oncological issues,…

WednesdayJun 14, 2017 9:00 am

Digital Currency Headed for Widespread Acceptance, Has Potential as Cure for Banking Concerns among Cannabis Companies

CannabisNewsWire Editorial Coverage: The cannabis market in the U.S. and worldwide continues to grow, but that doesn’t mean everyone is open to the idea of legal marijuana. The banking industry is one example, as the Federal Deposit Insurance Corporation (FDIC) has generally been unsupportive of backing cannabis-related investments. Since marijuana hasn’t been legalized at the federal level, most banks are hesitant to have any part of the $6.7 billion marijuana industry. While many industry experts expect this stance to change amid growing support for a bankable marijuana industry, 70 percent of cannabis companies currently operate without access to a corporate…

TuesdayJun 13, 2017 2:20 pm

Significant Milestones Put Player’s Network (PNTV) on the Radar

It’s been an exciting few months for Player’s Network, Inc. (OTCQB: PNTV), and the markets have reacted with increased interest in this active diversified holding company, which recently recorded its first revenues (http://nnw.fm/q9VCj), received its state-issued medical marijuana licenses (http://nnw.fm/8AbNW), and commenced operations at its 27,000-square-foot marijuana facility in North Las Vegas. These and other major milestones achieved so far in 2017 make PNTV an exciting company to watch. In February, PNTV uplisted to the OTCQB Venture Market and paid down most of its outstanding debt. While PNTV says it has always been fully reporting, moving to the OTCQB increases…